These results, which were in agreement with our bioinformatic analysis of the RNA sequencing data, prove that, PUS1 participates in RCC progression, indicating that PUS1 might have potential predictive value for prognosis of RCC in clinic. Here, PUS1 is linked to renal cell carcinoma.